These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2050347)

  • 21. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
    Camacho LM; Bartholomew NG; Joe GW; Cloud MA; Simpson DD
    Drug Alcohol Depend; 1996 May; 41(1):1-7. PubMed ID: 8793304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits.
    Fudala PJ; Johnson RE; Jaffe JH
    NIDA Res Monogr; 1990; 105():587-8. PubMed ID: 1876131
    [No Abstract]   [Full Text] [Related]  

  • 25. Another wall that crumbled--methadone maintenance treatment in Germany.
    Newman RG
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):27-35. PubMed ID: 7762542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
    Mendelson JH; Mello NK; Teoh SK; Kuehnle J; Sintavanarong P; Dooley-Coufos K
    NIDA Res Monogr; 1990; 105():196-202. PubMed ID: 1875999
    [No Abstract]   [Full Text] [Related]  

  • 28. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIDA's Medication Development Program--1989.
    Schuster CR; Snyder M
    NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056
    [No Abstract]   [Full Text] [Related]  

  • 31. Buprenorphine for cocaine and opiate dependence.
    Kosten TR; Rosen MI; Schottenfeld R; Ziedonis D
    Psychopharmacol Bull; 1992; 28(1):15-9. PubMed ID: 1609037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
    Compton PA; Ling W; Charuvastra VC; Wesson DR
    J Addict Dis; 1995; 14(3):97-114. PubMed ID: 8555282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experiences with levomethadone substitution in AIDS patients with intravenous drug dependence].
    Rüter O; Haardt B; Demelius S
    Offentl Gesundheitswes; 1991; 53(8-9):447-50. PubMed ID: 1837869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of buprenorphine and methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Am J Psychiatry; 1994 Jul; 151(7):1025-30. PubMed ID: 8010359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?
    Kosten TR; Rounsaville BJ; Kleber HD
    Arch Gen Psychiatry; 1987 Mar; 44(3):281-4. PubMed ID: 3827521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.
    Prendergast ML; Urada D; Podus D
    J Consult Clin Psychol; 2001 Jun; 69(3):389-405. PubMed ID: 11495169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in Buprenorphine- versus methadone-maintained patients.
    Schottenfeld RS; Pakes JR; Kosten TR
    J Nerv Ment Dis; 1998 Jan; 186(1):35-43. PubMed ID: 9457145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.
    Herbst MD; Batki SL; Manfredi LB; Jones T
    Psychiatr Serv; 1996 Feb; 47(2):119-20, 142. PubMed ID: 8825244
    [No Abstract]   [Full Text] [Related]  

  • 40. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.